It's Time For/Nonprofit Organization/San Antonio/Researching Type 1 Diabetes
Full list of Video Credit see here http://broadcaster.beazil.net/public/credits/youtube/videos/42357 Since its founding more than 40 years ago by parents of children affected by type 1 diabetes, the Juvenile Diabetes Research Foundation (JDRF) has been committed to finding a cure for all those individuals living with the disease. Today, JDRF acknowledges that this commitment will not likely be fulfilled in the near term. Although our ultimate goal—curing type 1 diabetes—remains unchanged, we are equally committed to better treating and preventing the disease. These goals aim to ensure that both children and adults living with type 1 diabetes remain healthy so that they can fully benefit from a cure when it becomes available. JDRF focuses on supporting the development and delivery of new therapies and devices that will ease the daily burden and challenges of managing type 1 diabetes and on the prevention of diabetes complications. Additionally, to protect future generations from developing type 1 diabetes, JDRF is supporting approaches to prevent the disease. San Antonio, officially the City of San Antonio, is the seventh most populated city in the United States of America and the second most populated city in the state of Texas, with a population of 1,409,019. It was the fastest growing of the top 10 largest cities in the United States from 2000 to 2010, and the second from 1990 to 2000. The city straddles Central Texas and South Texas and is on the southwestern corner of an urban megaregion known as the Texas Triangle. San Antonio serves as the seat of Bexar County. Recent annexations have extended the city’s boundaries into Medina County and, though for only a very tiny area near the city of Garden Ridge, into Comal County. The city has characteristics of other western urban centers in which there are sparsely populated areas and a low density rate outside of the city limits. San Antonio is the center of the San Antonio–New Braunfels Metropolitan Statistical Area. Health Care & Social Assistance sector comprises firms providing health care and social assistance for individuals. The sector includes both health care and social assistance because it is sometimes difficult to distinguish between the boundaries of these two activities. The industries in this sector are arranged on a continuum starting with providing medical care exclusively, continuing with those providing health care and social assistance and finally finishing with only social assistance. The services provided in this sector are delivered by trained health practitioners and social workers with requisite experience. Type 1 diabetes (T1D) is an autoimmune disease in which a person’s pancreas stops producing insulin. It occurs when the body’s immune system attacks and destroys the insulin-producing cells in the pancreas, called beta cells. While its causes are not yet entirely understood, scientists believe that both genetic factors and environmental triggers are involved. Its onset has nothing to do with diet or lifestyle. There is nothing you can do to prevent T1D, and—at present—nothing you can do to get rid of it. While people with T1D rely on insulin therapy to control their blood sugar, insulin is not a cure nor does it prevent the possibility of the disease’s serious side effects. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
It is important to note the main points –
donate today,preventive therapy research,Premixed insulin,T1D burden,Robert Wood Johnson IV,Research Pathways,Accredited Charity,Incretin-Based Therapies,insulin deficiency,Chapter Volunteer Outreach Chairs,brittle diabetes,Glucose Control,Diabetes Control and Complications Trial,Random Plasma Glucose Test,diabetes symptoms,injection site rotation,life-changing breakthroughs,A1C Test,Young Leadership Committee,Random Plasma Glucose Test,Neuropathy,glycemic control,San Antone,T1D Team,Affects of Diabetes,join,thiazolidinedione,TrialNet,precise,prediabetes,prevention,repaglinide,make a donation,volunteering,EsTiD,blood glucose level,Team Cure Diabetes,Blood Glucose Meters,Texas,A1C Limitations,Scientific,Insulin Pump Therapy,estimated average glucose,prevention of complications,LDL cholesterol,Insulin,diabetes diagnosis,Special Diabetes.